Trials / Sponsors / Paul Szabolcs
Paul Szabolcs
Academic / Other · 9 registered clinical trials — 9 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmun Common Variable Immunodeficiency (CVID), Primary Immune Regulatory Disorder, Immune Dysregulation | Phase 2 | 2026-03-01 |
| Enrolling By Invitation | Anti-viral T-cell Therapy by Gamma Capture Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections | Phase 1 / Phase 2 | 2024-01-08 |
| Recruiting | Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD) | — | 2020-08-20 |
| Recruiting | T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia | Phase 1 / Phase 2 | 2018-08-02 |
| Recruiting | Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease | Phase 2 | 2018-07-31 |
| Recruiting | Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure Idiopathic Pulmonary Fibrosis, Emphysema or COPD | Phase 1 / Phase 2 | 2018-04-19 |
| Recruiting | Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD) | Phase 2 | 2014-02-04 |
| Enrolling By Invitation | Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases Severe Combined Immunodeficiency (SCID), Immunodeficiency With Predominant T-cell Defect, Unspecified, Severe Chronic Neutropenia | Phase 1 / Phase 2 | 2013-06-20 |
| Recruiting | Autologous Stem Cell Transplantation for Crohn's Disease Crohn's Disease | Phase 1 / Phase 2 | 2012-06-26 |